Noesis Therapeutics

A scalable platform technology solution for drug developers in the neurological and neurodegenerative disease space, generating SaaS revenue. We have developed an in-silico model of whole-brain network dysfunction in disorders such as Lewy-Body dementia, Alzheimer’s disease and epilepsy. The model is trained using proprietary patient data with our team know-how of computational clinical neuroscience and artificial intelligence.